会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Noninvasive effective lung volume estimation
    • 无创有效肺容量估计
    • US07699788B2
    • 2010-04-20
    • US10973815
    • 2004-10-25
    • Kai KuckJoseph OrrLara Brewer
    • Kai KuckJoseph OrrLara Brewer
    • A61B5/00
    • A61B5/0836A61B5/091
    • Methods for noninvasively measuring, or estimating, functional residual capacity or effective lung volume include obtaining carbon dioxide and flow measurements at or near the mouth of a subject. Such measurements are obtained during baseline breathing and during and shortly after inducement of a change in the subject's effective ventilation. The obtained measurements are evaluated to determine the amount of time required for exhaled carbon dioxide levels to return to normal—effectively an evaluation of carbon dioxide “washout” from the subject's lungs. Conversely, carbon dioxide and flow measurements may be evaluated to determine the amount of time it takes carbon dioxide to “wash in,” or reach peak levels within, the lungs of the subject following the change in the subject's effective ventilation. Apparatus for effective such methods are also disclosed.
    • 用于非侵入性测量或估计功能残余容量或有效肺体积的方法包括在受试者的嘴部或附近获得二氧化碳和流量测量。 在基线呼吸期间和受试者的有效通气改变之后及之后不久,获得这些测量。 评估所获得的测量值,以确定呼出二氧化碳水平回复正常有效地评估受试者肺部二氧化碳“冲洗”所需的时间。 相反,可以评估二氧化碳和流量测量,以确定在受试者有效通气改变之后二氧化碳“洗涤”所需的时间,或达到受试者肺部内的峰值水平。 还公开了用于有效的这种方法的装置。
    • 3. 发明申请
    • Lung model-based cardiopulmonary performance determination
    • 肺型心肺功能测定
    • US20060004297A1
    • 2006-01-05
    • US11150378
    • 2005-06-10
    • Joseph OrrKai KuckLara Brewer
    • Joseph OrrKai KuckLara Brewer
    • A61B5/08
    • A61B5/029A61B5/082A61B5/083A61B5/0836A61B5/087A61B5/091G01N33/497
    • Methods for noninvasively evaluating indicators of cardio-pulmonary performance of a subject, such as cardiac output, pulmonary capillary blood flow, and blood carbon dioxide content, include obtaining data of an expiratory carbon dioxide signal and comparing data generated by an algorithmic lung model to the data of the expiratory carbon dioxide signal of a subject. The variables that are input into the algorithmic lung model are adjusted until the data generated thereby reflects that of the measured expiratory carbon dioxide signal with a desired degree of accuracy. Once the algorithmic lung model replicates the data of the measured expiratory carbon dioxide signal with the desired degree of accuracy, one or more of the input values may be used to determine one or more of the cardiac output, pulmonary capillary blood flow, or a blood gas content of the subject from which the expiratory carbon dioxide signal was obtained.
    • 用于非侵入性评估受试者的心肺功能指标(如心输出量,肺毛细血管血流量和血二氧化碳含量)的方法包括获得呼气二氧化碳信号的数据,并将算法肺模型产生的数据与 受检者呼气二氧化碳信号的数据。 调整输入到算法肺模型中的变量,直到由此产生的数据以所需的准确程度反映测量的呼气二氧化碳信号的数据。 一旦算法肺模型以期望的准确度复制测量的呼气二氧化碳信号的数据,则一个或多个输入值可用于确定心输出量,肺毛细血管血流量或血液中的一个或多个 获得呼气二氧化碳信号的对象的气体含量。
    • 6. 发明申请
    • Noninvasive effective lung volume estimation
    • 无创有效肺容量估计
    • US20050124907A1
    • 2005-06-09
    • US10973815
    • 2004-10-25
    • Kai KuckJoseph OrrLara Brewer
    • Kai KuckJoseph OrrLara Brewer
    • A61B5/083A61B5/091G01N1/22A61B5/08B32B5/02G01N31/00G01N33/497
    • A61B5/0836A61B5/091
    • Methods for noninvasively measuring, or estimating, functional residual capacity or effective lung volume include obtaining carbon dioxide and flow measurements at or near the mouth of a subject. Such measurements are obtained during baseline breathing and during and shortly after inducement of a change in the subject's effective ventilation. The obtained measurements are evaluated to determine the amount of time required for exhaled carbon dioxide levels to return to normal—effectively an evaluation of carbon dioxide “washout” from the subject's lungs. Conversely, carbon dioxide and flow measurements may be evaluated to determine the amount of time it takes carbon dioxide to “wash in,” or reach peak levels within, the lungs of the subject following the change in the subject's effective ventilation. Apparatus for effective such methods are also disclosed.
    • 用于非侵入性测量或估计功能残余容量或有效肺体积的方法包括在受试者的嘴部或附近获得二氧化碳和流量测量。 在基线呼吸期间和受试者的有效通气改变之后及之后不久,获得这些测量。 评估所获得的测量值,以确定呼出二氧化碳水平回复正常有效地评估受试者肺部二氧化碳“冲洗”所需的时间。 相反,可以评估二氧化碳和流量测量,以确定在受试者有效通气改变之后二氧化碳“洗涤”所需的时间,或达到受试者肺部内的峰值水平。 还公开了用于有效的这种方法的装置。
    • 7. 发明授权
    • System, method and apparatus for removal of volatile anesthetics for malignant hyperthermia
    • 用于去除恶性高热的挥发性麻醉剂的系统,方法和装置
    • US08800561B2
    • 2014-08-12
    • US13600952
    • 2012-08-31
    • Joseph OrrDwayne WestenskowDerek Sakata
    • Joseph OrrDwayne WestenskowDerek Sakata
    • A62B7/10A62B19/00A62B23/02A61M16/00
    • A61M16/009A61M16/0093A61M16/0816A61M16/105A61M16/1065A61M16/107
    • Systems, methods, and apparatus for removing volatile anesthetics from an anesthesia or ventilation system to minimize the effects of malignant hyperthermia in susceptible patients. According to one aspect of the present invention, a system for removing volatile anesthetics is provided. A first filter component placed in fluid communication with an inspiratory limb of an anesthesia or ventilation system such that volatile anesthetics will pass through the first filter component during operation of the anesthesia or ventilation system. A second filter component is operably coupled to the expiration port of the anesthesia or ventilation system such that gases passing through the expiratory limb of the anesthesia or ventilation system pass through the second filter component. The first filter component and second filter component are adapted to effectively remove volatile anesthetics passing through the respective filters.
    • 用于从麻醉或通气系统中去除挥发性麻醉剂的系统,方法和装置,以最小化易感患者的恶性高热的影响。 根据本发明的一个方面,提供了一种用于除去挥发性麻醉剂的系统。 第一过滤器部件与麻醉或通气系统的吸气肢流体连通,使得挥发性麻醉剂在麻醉或通气系统的操作期间将通过第一过滤器部件。 第二过滤器部件可操作地联接到麻醉或通气系统的呼气端口,使得穿过麻醉或通气系统的呼气肢体的气体通过第二过滤器部件。 第一过滤器部件和第二过滤器部件适于有效地去除通过各个过滤器的挥发性麻醉剂。
    • 8. 发明申请
    • System, Method and Apparatus for Removal of Volatile Anesthetics for Malignant Hyperthermia
    • 用于去除恶性热疗挥发性麻醉剂的系统,方法和装置
    • US20120325213A1
    • 2012-12-27
    • US13600952
    • 2012-08-31
    • Joseph OrrDwayne WestenskowDerek Sakata
    • Joseph OrrDwayne WestenskowDerek Sakata
    • A61M16/01A61M16/00
    • A61M16/009A61M16/0093A61M16/0816A61M16/105A61M16/1065A61M16/107
    • Systems, methods, and apparatus for removing volatile anesthetics from an anesthesia or ventilation system to minimize the effects of malignant hyperthermia in susceptible patients. According to one aspect of the present invention, a system for removing volatile anesthetics is provided. A first filter component placed in fluid communication with an inspiratory limb of an anesthesia or ventilation system such that volatile anesthetics will pass through the first filter component during operation of the anesthesia or ventilation system. A second filter component is operably coupled to the expiration port of the anesthesia or ventilation system such that gases passing through the expiratory limb of the anesthesia or ventilation system pass through the second filter component. The first filter component and second filter component are adapted to effectively remove volatile anesthetics passing through the respective filters.
    • 用于从麻醉或通气系统中去除挥发性麻醉剂的系统,方法和装置,以最小化易感患者的恶性高热的影响。 根据本发明的一个方面,提供了一种用于除去挥发性麻醉剂的系统。 第一过滤器部件与麻醉或通气系统的吸气肢流体连通,使得挥发性麻醉剂在麻醉或通气系统的操作期间将通过第一过滤器部件。 第二过滤器部件可操作地联接到麻醉或通气系统的呼气端口,使得穿过麻醉或通气系统的呼气肢体的气体通过第二过滤器部件。 第一过滤器部件和第二过滤器部件适于有效地去除通过各个过滤器的挥发性麻醉剂。
    • 9. 发明申请
    • SYSTEM, METHOD AND APPARATUS FOR REMOVAL OF VOLATILE ANESTHETICS FOR MALIGNANT HYPERTHERMIA
    • 用于移除恶性高血压的挥发性麻醉药物的系统,方法和装置
    • US20100269828A1
    • 2010-10-28
    • US12431644
    • 2009-04-28
    • Joseph OrrDwayne WestenskowDerek Sakata
    • Joseph OrrDwayne WestenskowDerek Sakata
    • A61M16/00
    • A61M16/009A61M16/0093A61M16/0816A61M16/105A61M16/1065A61M16/107
    • Systems, methods, and apparatus for removing volatile anesthetics from an anesthesia or ventilation system to minimize the effects of malignant hyperthermia in susceptible patients. According to one aspect of the present invention, a system for removing volatile anesthetics is provided. A first filter component placed in fluid communication with an inspiratory limb of an anesthesia or ventilation system such that volatile anesthetics will pass through the first filter component during operation of the anesthesia or ventilation system. A second filter component is operably coupled to the expiration port of the anesthesia or ventilation system such that gases passing through the expiratory limb of the anesthesia or ventilation system pass through the second filter component. The first filter component and second filter component are adapted to effectively remove volatile anesthetics passing through the respective filters.
    • 用于从麻醉或通气系统中去除挥发性麻醉剂的系统,方法和装置,以最小化易感患者的恶性高热的影响。 根据本发明的一个方面,提供了一种用于除去挥发性麻醉剂的系统。 第一过滤器部件与麻醉或通气系统的吸气肢流体连通,使得挥发性麻醉剂在麻醉或通气系统的操作期间将通过第一过滤器部件。 第二过滤器部件可操作地联接到麻醉或通气系统的呼气端口,使得穿过麻醉或通气系统的呼气肢体的气体通过第二过滤器部件。 第一过滤器部件和第二过滤器部件适于有效地去除通过各个过滤器的挥发性麻醉剂。